REGINfo: MSI - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

INDEX SEARCH RESULT

2020.11.25 | 07:15 | Permanent Information Releases / General Company News

NESTLE

puce Nestlé agrees to sell Yinlu peanut milk and canned rice porridge businesses to Food Wise Co., Ltd. - HTML (w)

2020.11.25 | 07:00 | Permanent Information Releases / General Company News

CLARIANT

puce Clariant strengthens its core by transforming the portfolio, focusing and rightsizing its organization - HTML (w)

2020.11.24 | 07:00 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis highlights confidence in growing sales with margin expansion, fueled by in-market brands and a rich pipeline, at Annual Meet the Management investor event - HTML (w)

2020.11.24 | 07:00 | Permanent Information Releases / General Company News

ROCHE

puce Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person - HTML (w)

2020.11.19 | 22:30 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy - HTML (w)

2020.11.19 | 15:43 | Permanent Information Releases / General Company News

NOVARTIS

puce New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases - HTML (w)

2020.11.19 | 07:15 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis set to achieve 100% renewable electricity in its European operations - HTML (w)

2020.11.19 | 07:00 | Permanent Information Releases / General Company News

SIKA

puce SIKA EXPANDIERT IN DUBAI UND BAUT FERTIGUNG AUS - HTML (w)

2020.11.19 | 07:00 | Permanent Information Releases / General Company News

SIKA

puce SIKA EXPANDS OPERATIONS IN DUBAI AND INCREASES PRODUCTION - HTML (w)

2020.11.16 | 07:00 | Permanent Information Releases / General Company News

ROCHE

puce Roche zum elften Mal als nachhaltigstes Gesundheitsunternehmen im Dow Jones Sustainability Index ausgezeichnet - HTML (w)

2020.11.16 | 07:00 | Permanent Information Releases / General Company News

ROCHE

puce Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the eleventh time - HTML (w)

2020.11.13 | 17:00 | Permanent Information Releases / General Company News

ROCHE

puce CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza - HTML (w)

2020.11.13 | 16:50 | Permanent Information Releases / Sales and Revenues

VIFOR PHARMA

puce Full Results From AFFIRM-AHF Study Show Ferinject® Significantly Reduces Hospitalizations After Acute Heart Failure in Patients With Iron Deficiency - HTML (w)

2020.11.13 | 16:00 | Permanent Information Releases / General Company News

NOVARTIS

puce New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender - HTML (w)

2020.11.13 | 14:00 | Permanent Information Releases / General Company News

ROCHE

puce CHMP recommends EU approval of Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1000